Income statement, balance sheet and cash flow statement for the last 9 fiscal years, taken from the XBRL data Personalis, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2017
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
9.39
37.8
65.2
78.6
85.5
65
73.5
84.6
69.6
Cost of revenue
11.7
26
43.1
58.5
53.8
51.7
55.3
57.8
53.9
Gross profit
-2.34
11.8
22.1
20.1
31.7
13.4
18.2
26.8
15.8
Research and development
9.92
14.3
22.4
28.6
49.3
64.9
64.8
48.9
50.3
Selling, general and administrative
9.9
11.3
22.1
33.7
47.7
64
49.7
46.2
53.6
Operating income
-22.2
-13.8
-22.4
-42.1
-65.4
-116
-110
-68.3
-88.1
Interest expense
1.3
1.89
1.13
0
0.18
0.2
0.11
0.02
0.21
Interest income
0.1
0.29
1.62
0.95
0.37
2.4
5.9
5.51
7.16
Other non-operating income
-0.23
0.15
-1.44
-0.02
-0.04
0.06
-4.07
-18.5
-0.14
Pre-tax income
-23.6
-19.9
-25.1
-41.2
-65.2
-113
-108
-81.3
-81.2
Income tax
0.01
0.01
0.01
0.06
0.01
0.04
0.08
0.02
0.02
Net income
-23.6
-19.9
-25.1
-41.3
-65.2
-113
-108
-81.3
-81.3
EBITDA
-20.9
-10.7
-17.7
-36.4
-59.3
-107
-98.6
-57.3
-78
EPS, basic
-7.78
-6.49
-1.39
-1.20
-1.49
-2.48
-2.25
-1.37
-0.91
EPS, diluted
-7.78
-6.49
-1.39
-1.20
-1.49
-2.48
-2.25
-1.37
-0.91
Shares, basic (weighted)
3.04
3.06
18
34.4
43.9
45.7
48.2
59.3
89.2
Shares, diluted (weighted)
3.03
3.06
18
34.4
43.9
45.7
48.2
59.3
89.2
Balance sheet
FY2017
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
22.6
19.7
55
68.5
106
89.1
57
91.4
124
Short-term investments
73.2
135
181
78.5
57.2
93.6
116
Receivables
4.46
3.3
6.35
18.5
16.6
17.7
8.14
16.2
Other current assets
1.93
3.38
5.44
7.09
6.81
4.36
3.93
5.65
Total current assets
29.6
140
221
318
200
147
203
268
Property, plant and equipment
11.5
14.1
11.8
19.7
61.9
57.4
48.3
44.8
Lease right-of-use assets
1.85
10.3
53.8
26.5
17.9
16.5
15.1
Other non-current assets
0.66
1.76
2.02
4.83
4.59
3.14
2.53
6.28
Total assets
41.7
157
245
397
293
225
270
334
Accounts payable
6.57
7.34
8.3
9.22
12.9
14.9
6.4
13
Accrued liabilities
0.06
0.69
0.31
0.88
1.7
0.86
8.54
6.96
Deferred revenue
42.9
36
21
3.98
1.26
3.29
3.1
1.56
Short-term debt
5
Total current liabilities
57.9
50
40.6
31.3
33.1
47.2
31.1
39.6
Lease liabilities
0.64
8.54
52.8
41
38.3
34.9
31.9
Other non-current liabilities
0.12
0.64
0.72
2.12
0.39
5.16
1.3
1.48
Total liabilities
58.7
50.6
49.9
86.2
74.6
95.7
67.3
73
Total debt
5
Paid-in capital
9.13
247
377
558
579
598
753
892
Retained earnings
-116
-141
-182
-247
-360
-469
-550
-631
Other comprehensive income
-0.02
-0.01
0.02
-0.17
-0.91
-0.22
-0.02
0.1
Shareholders' equity
-92.6
-106
107
195
310
218
129
203
261
Total equity
-92.6
-106
107
195
310
218
129
203
261
Total liabilities and equity
41.7
157
245
397
293
225
270
334
Shares outstanding
3.09
31.2
39.1
44.9
46.7
50.5
85.2
102
Cash flow statement
FY2017
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-23.6
-19.9
-25.1
-41.3
-65.2
-113
-108
-81.3
-81.3
Depreciation and amortization
1.22
3.07
4.75
5.76
6.01
8.43
11.3
10.9
10
Stock-based compensation
0.75
1.32
4.86
8.24
14.4
19.4
14.1
10.7
9.43
Deferred income tax
-0.03
-0.03
0.05
-0
-0
Change in receivables
-1.2
-2.52
1.07
-3.05
-12.1
1.83
-1.09
9.59
-8.06
Change in payables
2.64
2.16
1.4
0.75
-1.46
3.09
5.18
-8.92
4.55
Cash from operations
0.29
5.57
-18.1
-42.7
-70.8
-70.2
-56.3
-45.2
-74.9
Capital expenditures
-5.16
-7.85
-8.38
-3.25
-11.1
-49.9
-10.9
-1.6
-4.5
Purchases of investments
-78.9
-162
-267
-121
-104
-122
-210
Sales and maturities of investments
5.7
99.9
213
224
128
88
192
Cash from investing
-5.16
-7.85
-81.6
-65.1
-60.1
52.5
13.1
-35.1
-22.6
Debt issued
17.2
20
Debt repaid
-0.82
-0.65
-25
Stock issued
0.07
0.08
144
118
162
2.47
3.51
30.1
127
Cash from financing
16.4
-0.59
135
121
170
1.37
11
115
130
Net change in cash
11.5
-2.87
35.3
13.5
38.9
-16.5
-32.1
34.4
32.8
Free cash flow
-4.87
-2.28
-26.5
-45.9
-81.9
-120
-67.2
-46.8
-79.5
Interest paid
0.32
0.7
1.26
Income taxes paid
0.01
0.01
0.01
0.04
0.04
0.05
0.06
0.04
0.02
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $16.46 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
12.7%
Gross profit / revenue.
Operating margin
-164.1%
Operating income / revenue.
EBITDA margin
-150.2%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-153.8%
Pre-tax income / revenue.
Net margin
-153.8%
Net income / revenue.
FCF margin
-144.9%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-132.5%
Cash from operations / revenue.
Return on equity (ROE)
-45.6%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-34.3%
Net income / average total assets.
Return on invested capital (ROIC)
-64.0%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
80.5%
Research and development expense / revenue.
SG&A / revenue
96.2%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
15.7%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
12.5%
Capital expenditures / revenue.
D&A / revenue
13.9%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-17.7%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
2.3%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-2.4%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-41.2%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
5.7%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-4.7%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
28.7%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
6.2%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
6.0%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
23.6%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
4.5%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
6.4%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
50.6%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
25.0%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
21.0%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
5.28x
Current assets / current liabilities.
Quick ratio
4.91x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
4.58x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.66
Revenue / diluted weighted shares.
FCF per share
-$0.96
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.88
Cash from operations / diluted weighted shares.
Book value per share
$2.21
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
25.2x
Market cap / revenue.
P/B
7.48x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
7.48x
Market cap / tangible book value, when positive.
EV/Sales
22.2x
Enterprise value / revenue.
FCF yield
-5.7%
Free cash flow / market cap.
Earnings yield
-6.1%
Net income / market cap (the inverse of P/E).
What was Personalis, Inc.'s revenue in fiscal 2025?
Personalis, Inc. reported revenue of $69.6M for fiscal 2025, 17.7% lower than the year before.
Was Personalis, Inc. profitable in fiscal 2025?
No. It reported a net loss of $81.3M.
How much free cash flow did Personalis, Inc. generate in fiscal 2025?
Cash from operations of $74.9M minus capital expenditures of $4.5M left free cash flow of -$79.5M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.